US Merck Products
Scroll down or use the filters to find a product.
JANUMET® (sitagliptin and metformin HCI) 50/500 mg, 50/1000 mg tablets and JANUMET® XR (sitagliptin and metformin HCI extended-release) 50/500 mg, 50/1000 mg, 100/1000 mg tablets
Before prescribing JANUMET or JANUMET XR, please read the Prescribing Information, including the Boxed Warning about lactic acidosis.
ONTRUZANT®
(trastuzumab-dttb) for injection, for intravenous use 21 mg/mL
Before prescribing ONTRUZANT, please read the Prescribing Information, including the Boxed Warning about cardiomyopathy, infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
PIFELTRO™ (doravirine 100 mg) tablets and DELSTRIGO™ (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) tablets
Before prescribing PIFELTRO, please read the accompanying Prescribing Information. The Patient Information also is available. Before prescribing DELSTRIGO, please read the accompanying Prescribing Information, including the Boxed Warning about posttreatment acute exacerbation of Hepatitis B. The Patient Information also is available.
.png)
RENFLEXIS®
(infliximab-abda) for injection, for intravenous use 100 mg
Before prescribing RENFLEXIS, please read the Prescribing Information, including the Boxed Warning about serious infections and malignancies.
SEGLUROMET™
(ertugliflozin and metformin HCI) 2.5 mg/500 mg, 2.5 mg/1000 mg, 7.5 mg/500 mg, 7.5 mg/1000 mg tablets)
Before prescribing SEGLUROMET, please read the Prescribing Information, including the Boxed Warning about lactic acidosis.
ZEPATIER®
(elbasvir and grazoprevir) 50 mg/100 mg tablets, for oral use
Before prescribing ZEPATIER, please read the Prescribing Information, including the Boxed Warning about the risk of hepatitis B virus (HBV) reactivation in patients with HBV coinfection.
